Certain advanced breast cancer patients may benefit from surgery before other treatment, study finds

December 12, 2013

Patients newly diagnosed with advanced breast cancer and a solitary bone metastasis could benefit from surgery prior to other treatment, according to early results from a first-of-its kind clinical trial presented today at the 2013 San Antonio Breast Cancer Symposium.

"In the U.S., approximately 5 percent of are diagnosed with advanced disease when they first see their physician," said Atilla Soran, M.D., a breast surgical oncologist with Magee-Womens Hospital of UPMC and the study's lead investigator. "Around the world, that percentage can go as high as 10 percent. Current standard of care recommends avoiding surgery in these patients and prescribing systemic therapy and radiation therapy instead. Previous research, however, has shown that surgery can actually prolong survival in other advanced cancers and we wanted to see if the same held true for breast cancer."

As a Turkish native, Dr. Soran approached the Turkish Federation of Societies for Breast Diseases about conducting a clinical trial to test the of such a treatment approach. In 2007, under scientific advisement with UPMC, the trial launched.

The study enrolled 278 patients with from across Turkey, 140 of whom underwent surgery. The primary goal of the study was to assess whether early surgical treatment in women with advanced disease could affect overall survival.

"Our initial results don't show any difference in survival rates, but we are early in the follow-up phase," said Dr. Soran. "However, we did notice that one patient subgroup – patients with a singular metastasis to the bone – is trending toward prolonged survival."

Patients with aggressive forms of the disease, and patients with multiple metastases on the liver and lungs, derived less benefit from the treatment approach.

"Breast cancer isn't just a U.S. concern – it's a global disease. We will continue our follow-up and reporting from this clinical trial for several years to come, and hopefully our study will help women here at home and abroad by improving our understanding of how to best treat it," said Dr. Soran.

Explore further: Avoiding radiotherapy is an option for some older patients with breast cancer

Related Stories

Avoiding radiotherapy is an option for some older patients with breast cancer

December 11, 2013
Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer, according to results ...

Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy

December 11, 2013
After a response to initial chemotherapy, treatment with radiotherapy and surgical removal of the breast tumor and nearby lymph nodes do not provide any additional benefit to patients with metastatic breast cancer, according ...

Researchers to present event-free and overall survival results from NeoALTTO trial

December 11, 2013
Results from the initial analysis of event-free and overall survival for patients enrolled in the randomized, phase III Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimization (NeoALTTO) trial are to be presented ...

High levels of immune cells in tumors may ID breast cancer pts most likely benefit from trastuzumab

December 11, 2013
Women with HER2-positive breast cancer who had the highest levels of immune cells in their tumors gained the most benefit from presurgery treatment with chemotherapy and trastuzumab, according to results presented here at ...

Studies: Some cancer treatments can be skipped

December 11, 2013
Tens of thousands of women each year might be able to skip at least some of the grueling treatments for breast cancer—which can include surgery, heavy chemo and radiation—without greatly harming their odds of survival, ...

When breast cancer spreads to lungs, surgery may increase survival

April 1, 2013
(HealthDay)—Patients with breast cancer that has spread to the lungs may live longer if they have surgery to remove the lung tumors, a new study from Germany suggests.

Recommended for you

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.